milrinone has been researched along with propranolol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Evenou, JP; Hof, A; Hof, RP; Novosel, D | 1 |
| Belluco, P; Borea, PA; Dorigo, P; Gaion, RM; Maragno, I; Mosti, L | 1 |
| Armah, BI; Brasch, H; Iven, H | 1 |
| Riley, CM | 1 |
| Hino, M; Ono, H; Takase, M; Yamazaki, H; Yoshimura, A; Yoshioka, K | 1 |
| Farah, A; Kabela, E; Mendez, R; Pastelin, G | 1 |
| Naito, H; Nishimoto, C; Okubo, N; Sato, S; Tsuji, MH | 1 |
| Naito, H; Okubo, N; Sato, S; Tsuji, MH | 1 |
| Carpenedo, F; Dorigo, P; Floreani, M; Fraccarollo, D; Gaion, RM; Jester, M; Maragno, I; Mosti, L; Santostasi, G; Schenone, P | 1 |
| Borea, PA; Dorigo, P; Floreani, M; Fraccarollo, D; Gaion, RM; Maragno, I; Mosti, L; Santostasi, G | 1 |
| Bjerkås, H; Helle, KB; Lønning, K | 1 |
| Brukstus, A; Dauksas, V; Garaliené, V; Labanauskas, L | 1 |
| Hashiba, E; Hashimoto, Y; Hirota, K; Kudo, T; Matsuki, A; Sato, T; Yoshioka, H | 1 |
| Aleixandre, F; Carceles, MD; Fuente, T; Laorden, ML; López-Vidal, J | 1 |
| Bobalova, J; Mutafova-Yambolieva, VN; Smyth, L | 1 |
| Atarashi, H; Hirayama, Y; Kameyama, M; Maruyama, M; Saitoh, H; Takano, T | 1 |
| Berg, T; Degerman, E; Tasken, K | 1 |
1 review(s) available for milrinone and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
22 other study(ies) available for milrinone and propranolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart Failure; Heart Rate; Milrinone; Myocardial Contraction; Nitroprusside; Ouabain; Propranolol; Pyridones; Rabbits; Vagotomy; Vasodilator Agents | 1992 |
An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Carbachol; Cardiotonic Agents; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Phenylisopropyladenosine; Propranolol; Pyridones; Reserpine; Theophylline | 1991 |
Electrophysiologic effects of saterinone and milrinone in the isolated guinea pig myocardium.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Electrophysiology; Guinea Pigs; Heart; Heart Atria; Milrinone; Papillary Muscles; Phosphodiesterase Inhibitors; Piperazines; Propranolol; Pyridones; Tetrodotoxin | 1988 |
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.
Topics: Digoxin; Drug Combinations; Drug Stability; Drug Storage; Furosemide; Glucose; Indicators and Reagents; Milrinone; Procainamide; Propranolol; Pyridones; Quinidine; Solutions; Temperature; Verapamil | 1988 |
Cardiotonic activity of 5-methyl-6-(4-pyridyl)-2H-1,4-thiazin-3(4H)-one hydrochloride (ZSY-27).
Topics: Animals; Cardiotonic Agents; Cats; Dogs; Female; Guinea Pigs; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Pentobarbital; Propranolol; Pyridones; Thiazines | 1988 |
The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
Topics: Animals; Cardiotonic Agents; Dinitrophenols; Dogs; Heart; Heart Failure; Milrinone; Nifedipine; Papaverine; Pentobarbital; Propranolol; Pyridones; Theophylline | 1983 |
Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model.
Topics: Animals; Cardiotonic Agents; Dogs; Drug Therapy, Combination; Glucagon; Heart Rate; Milrinone; Poisoning; Propranolol; Pyridones; Vascular Resistance | 1995 |
Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning.
Topics: Animals; Cardiotonic Agents; Dogs; Glucagon; Heart; Hemodynamics; Infusion Pumps; Injections, Intravenous; Milrinone; Propranolol; Pulmonary Circulation; Pyridones | 1994 |
Pharmacological characterization of a new milrinone analogue.
Topics: Adenosine Deaminase; Animals; Cardiotonic Agents; Electric Stimulation; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Milrinone; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Propranolol; Pyridones; Reserpine | 1994 |
New inotropic agents: milrinone analogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Animals; Atrial Function; Binding, Competitive; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Myocardium; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Propranolol; Pyridones; Quinolones; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Reserpine | 1997 |
The adrenomedullary venous vasculature as a target for endothelins: comparison of the porcine and bovine central adrenomedullary veins.
Topics: Acetylcholine; Adenylyl Cyclases; Adrenal Medulla; Animals; Caffeine; Cattle; Colforsin; Cyclic AMP; Endothelin-1; Milrinone; Muscle, Smooth, Vascular; Neuropeptide Y; Potassium; Propranolol; Receptor, Endothelin A; Receptors, Endothelin; Second Messenger Systems; Species Specificity; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Veins | 1998 |
Synthesis and positive inotropic effects of 1-acyl-5,6-diethoxy-2-methylthiobenzimidazoles.
Topics: Adrenergic beta-Antagonists; Animals; Benzimidazoles; Carbachol; Cardiotonic Agents; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Parasympathomimetics; Propranolol; Spectrophotometry, Infrared | 1998 |
Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs.
Topics: Animals; Bronchoconstriction; Catecholamines; Dogs; Hypertension, Pulmonary; Milrinone; Phosphodiesterase Inhibitors; Propranolol; Serotonin | 2000 |
Combined phosphodiesterase inhibition and beta-blockade in the GI104313, decreases ischemia-induced arrhythmias in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Hemodynamics; Male; Milrinone; Myocardial Ischemia; Myocardium; Nitriles; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Propranolol; Pyridazines; Rats; Rats, Sprague-Dawley | 2001 |
Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Animals; Autonomic Nervous System; Bucladesine; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dogs; Edetic Acid; Electric Stimulation; Isoproterenol; Mesenteric Arteries; Mesenteric Veins; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Propranolol; Rolipram; Second Messenger Systems | 2003 |
Possible contribution of the sarcoplasmic reticulum Ca(2+) pump function to electrical and mechanical alternans.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adrenergic beta-Agonists; Animals; Calcium; Calcium Signaling; Catecholamines; Cell Polarity; Dogs; Electric Conductivity; Female; Heart Block; Ion Pumps; Isoproterenol; Male; Milrinone; Propranolol; Sarcoplasmic Reticulum; Thapsigargin | 2003 |
Increased cAMP signaling can ameliorate the hypertensive condition in spontaneously hypertensive rats.
Topics: Adenylate Cyclase Toxin; Animals; Aorta; Blood Pressure; Cardiac Output; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Femoral Artery; Hypertension; Male; Milrinone; Muscle, Striated; Phenylephrine; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thionucleotides; Tyramine; Vascular Resistance | 2009 |